Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Goldberg-Shprintzen syndrome

Congenital Malformations and Chromosomal Abnormalities

Goldberg-Shprintzen syndrome is a very rare connective tissue condition associated with mutations in the KIAA1279 gene, which encodes KIF-binding protein, a protein that may interact with microtubules and actin filaments and may play a key role in cytoskeleton formation and neurite growth. Hirschsprung disease may be part of the presentation, and developmental abnormalities may be ocular, cardiac, urogenital and skeletal. The condition was first observed by Sugarman and Vogel in 1981 and was established as a separate clinical identity by R B Goldberg and R J Shprintzen in 1982, describing a sibling pair with microcephaly, hypertelorism, short stature, submucosal cleft palate, learning problems and Hirschsprung aganglionic megacolon. Three more cases were reported in 1988 by Hurst and colleagues, although one of them may have been Mowat-Wilson syndrome instead. Further cases have been documented sporadically worldwide, but it remains extremely uncommon.

Facts
Classification
ICD-10 Chapter
XVII: Congenital Malformations, Deformations and Chromosomal Abnormalities 1
Communicable or Non-communicable
Non-Communicable 2
Causative Agent
Causative Agent (category)
Genetic / Hereditary 2
First Described
1981 2
Sources
1. World Health Organization ICD-10: ICD-10 Version:2019 - Q80-Q89
World Health Organization ICD-10Category Q87.8
Quote, Category Q87.8
Q87.8 Other specified congenital malformation syndromes,
View the Source
2. Goldberg-Shprintzen syndrome (Wikipedia)
  • Lead
    associated with mutations in KIAA1279 gene
  • History
    It was first observed by Sugarman and Vogel in 1981
  • Lead: disease category
    Goldberg-Shprintzen syndrome is a very rare connective tissue condition associated with mutations in KIAA1279 gene which encodes KIF-binding protein (KBP), a protein that may interact with microtubules and actin filaments.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.